Satishkumar Singh

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 7 papers. Top paper: “PRMT5 inhibition drives therapeutic vulnerability to combination treatment with BCL-2 inhibition in mantle cell lymphoma”.

PRMT5 inhibition drives therapeutic vulnerability to combination treatment with BCL-2 inhibition in mantle cell lymphoma

Blood Advances(2023)10.1182/bloodadvances.2023009906

N/A

0.607DataRank · unranked

16 citations

Inah Hwang, Shelby Sloan, Claire Hinterschied, JoBeth Helmig-Mason, Mackenzie Long +19 more

Inhibition of Bromodomain and Extra Terminal (BET) Domain Activity Modulates the IL-23R/IL-17 Axis and Suppresses Acute Graft-Versus-Host Disease

Frontiers in Oncology(2021)10.3389/fonc.2021.760789

N/A

0DataRank · unranked

18 citations

Hannah Choe, Yandi Gao, Natalie E. Sell, Kara M. Braunreiter, Nina C. Zitzer +13 more

RETRACTED ARTICLE: AKT3-mediated IWS1 phosphorylation promotes the proliferation of EGFR-mutant lung adenocarcinomas through cell cycle-regulated U2AF2 RNA splicing

Nature Communications(2021)10.1038/s41467-021-24795-1

N/A

0DataRank · unranked

15 citations

Evangelia Chavdoula, Maria D. Paraskevopoulou, Abdul Kaba, Alessandro La Ferlita, Satishkumar Singh +15 more

Phospho-IWS1-dependent U2AF2 splicing is cell-cycle-regulated, promotes proliferation and predicts poor prognosis of EGFR- mutant lung adenocarcinoma

bioRxiv (Cold Spring Harbor Laboratory)(2020)10.1101/2020.07.14.195297

N/A

0DataRank · unranked

0 citations

Evangelia Chavdoula, Maria D. Paraskevopoulou, Abdul D. Kaba, Alessandro La Ferlita, Satishkumar Singh +15 more

Exploiting the fibroblast growth factor receptor-1 vulnerability to therapeutically restrict the MYC-EZH2-CDKN1C axis-driven proliferation in Mantle cell lymphoma

Leukemia(2023)10.1038/s41375-023-02006-8

N/A

0DataRank · unranked

13 citations

Satishkumar Singh, Zijun Y. Xu‐Monette, Krysta M. Coyle, Laura K. Hilton, Evangelia Chavdoula +14 more

Epidermal growth factor-like 7 is a novel therapeutic target in mantle cell lymphoma

Experimental Hematology(2023)10.1016/j.exphem.2023.05.003

N/A

0DataRank · unranked

2 citations

Sofia Kolovich, Alexander Rudich, Malith Karunasiri, Rohan Kulkarni, Girish Rajgolikar +8 more

Overexpression of the SETD2 WW domain inhibits the phosphor-IWS1/SETD2 interaction and the oncogenic AKT/IWS1 RNA splicing program

bioRxiv (Cold Spring Harbor Laboratory)(2021)10.1101/2021.08.12.454141

N/A

0DataRank · unranked

0 citations

Evangelia Chavdoul, Vollter Anastas, Satishkumar Singh, Adam D. Kenney, Samir Acharya +4 more